Cognitive correlates of a functional COMT polymorphism in children with 22q11.2 deletion syndrome
- 8 February 2006
- journal article
- Published by Wiley in Clinical Genetics
- Vol. 69 (3) , 234-238
- https://doi.org/10.1111/j.1399-0004.2006.00569.x
Abstract
Chromosome 22q11.2 deletion syndrome (22q11DS) is a common microdeletion syndrome associated with a markedly elevated risk of schizophrenia in adulthood. Cognitive impairments such as a low IQ and deficits in attention and executive function are common in childhood. The catechol O-methyltransferase (COMT) gene maps within the deleted region and is involved in the degradation of dopamine, a neurotransmitter thought to be important in cognition and the development of schizophrenia. Thus, we examined the correlation between neurocognitive deficits and a common polymorphism Val(158)Met in the COMT gene in a cohort of children with 22q11DS. Our results show that children with 22q11DS who have the Met allele have higher IQ and achievement scores and perform better on measures of prefrontal cognition, such as the Continuous Performance Task, as compared with those with the Val allele. These results confirm that the hemizygous COMT Val(158)Met genotype impacts upon cognition in children with 22q11DS.Keywords
This publication has 33 references indexed in Scilit:
- Effects of a Functional COMT Polymorphism on Prefrontal Cognitive Function in Patients With 22q11.2 Deletion SyndromeAmerican Journal of Psychiatry, 2004
- Attention disorders in schizophreniaPsychiatry and Clinical Neurosciences, 2004
- Association between Val108/158met polymorphism of theCOMTgene and schizophreniaAmerican Journal Of Medical Genetics Part B-Neuropsychiatric Genetics, 2003
- Higher scores of self reported schizotypy in healthy young males carrying the COMT high activity alleleMolecular Psychiatry, 2002
- A Functional Polymorphism in the COMT Gene and Performance on a Test of Prefrontal CognitionAmerican Journal of Psychiatry, 2002
- Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disordersPharmacogenetics, 1996
- Preferential transmission of the high activity allele of COMT in schizophreniaPsychiatric Genetics, 1996
- Catechol O-methyltransferase pharmacogenetics: photoaffinity labelling and Western blot analysis of human liver samplesPharmacogenetics, 1993
- Late‐Onset psychosis in the velo‐cardio‐facial syndromeAmerican Journal of Medical Genetics, 1992
- Global attentional deviance as a marker of risk for schizophrenia: Specificity and predictive validity.Journal of Abnormal Psychology, 1985